Table 3. Treatments and outcomes of non-severe or severe patients of COVID-19 in Guangzhou.
No. (%) | P value | |||
Total (288) | Non-severe (258) | Severe (30) | ||
Treatments | ||||
Antiviral | 233(80.9) | 204(79.1) | 29(96.7) | 0.020 |
Antibiotics | 244(84.7) | 214(82.9) | 30(100) | 0.014 |
Vasoactive drugs | 5(1.7) | 1(0.4) | 4(13.3) | <0.0001 |
Glucocorticoid | 21(7.3) | 12(4.7) | 9(30) | <0.0001 |
CRRT | 5(1.7) | 0(0) | 5(16.7) | <0.0001 |
ECMO | 4(1.4) | 0(0) | 4(13.3) | <0.0001 |
Oxygen uptake: | .. | .. | .. | .. |
None | 88(30.6) | 84(32.6) | 4(13.3) | 0.030 |
Normal-flux | 184(63.9) | 171(66.3) | 13(43.3) | 0.013 |
High-flux | 16(5.6) | 3(1.2) | 13(43.3) | <0.0001 |
Tracheal intubation | 8(2.8) | 0(0) | 8(26.7) | <0.0001 |
Tracheotomy | 0(0) | 0(0) | 0(0) | .. |
Non-invasive mechanical ventilation | 32(11.1) | 13(5) | 19(63.3) | <0.0001 |
Outcomes | ||||
ICU Admission | 27(9.4) | 12(4.7) | 15(50) | <0.0001 |
ARDS | 3(1) | 0(0) | 3(10) | <0.0001 |
Acute kidney injury | 5(1.7) | 0(0) | 5(16.7) | <0.0001 |
Acute cardiac injury | 22(11.6) | 13(7.6) | 9(50) | <0.0001 |
CRRT, continuous renal-replacement therapy; ECMO, Extracorporeal membrane oxygenation; ICU, intensive care unit; ARDS, Acute respiratory distress syndrome.
*P values indicate differences between Severe and Non-severe patients. P<0.05 was considered statistically significant.